Drug Type Monoclonal antibody |
Synonyms |
Target |
Action inhibitors |
Mechanism CDH1 inhibitors(cadherin 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | Preclinical | Netherlands | 03 Jun 2024 | |
Lynch Syndrome II | Preclinical | Netherlands | 03 Jun 2024 |